Copertina

Natural products and cancer: From drug discovery to prevention and therapy

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Angelo A. Izzo, Barbara Stefanska
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Immunotherapy in cancer: novel approaches and future perspectives
di: Barbara Stefanska, et al.
Pubblicazione: (2025)

Natural product pharmacology: the British Journal of Pharmacology perspective
di: Xin Wang, et al.
Pubblicazione: (2024)

Have plastic culture models prevented the discovery of effective cancer therapeutics?
di: Kevin M. Tharp
Pubblicazione: (2024)

EpigenPlot: An interactive web platform for DNA methylation‐based biomarker and drug target discovery in colorectal cancer
di: Dalma Müller, et al.
Pubblicazione: (2025)

Updated BJP guidelines for transparent and rigorous natural product research
di: Xin Wang, et al.
Pubblicazione: (2026)

Artificial intelligence streamlines scientific discovery of drug–target interactions
di: Yuxin Yang, et al.
Pubblicazione: (2025)

Drug–drug interactions between gender‐affirming hormone therapy and antiretrovirals for treatment/prevention of HIV
di: Tessa Senneker
Pubblicazione: (2024)

Recent advances in neuroinflammation prevention and therapy: the role of natural products and underlying mechanisms based on molecular targets
di: Mei‐Mei Zhao, et al.
Pubblicazione: (2024)

Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review
di: Stavros Topouzis, et al.
Pubblicazione: (2025)

Reporting innovations in pharmacology and drug development, upholding excellence and improving author experience at the British Journal of Pharmacology in 2024
di: Andreas Papapetropoulos, et al.
Pubblicazione: (2025)

Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer
di: Ana Rita Simoes, et al.
Pubblicazione: (2025)

Altered desensitization and internalization patterns of rodent versus human glucose‐dependent insulinotropic polypeptide (GIP) receptors. An important drug discovery challenge
di: Lærke Smidt Gasbjerg, et al.
Pubblicazione: (2024)

MicroRNA‐guided drug discovery for mitigating persistent pulmonary complications in critical COVID‐19 survivors: A longitudinal pilot study
di: María C. García‐Hidalgo, et al.
Pubblicazione: (2024)

Systematic drug screening and target analysis identify digitoxin as a potential therapy for uveal melanoma
di: Huilin Liu, et al.
Pubblicazione: (2024)

System level network data and models attack cancer drug resistance
di: Márk Kerestély, et al.
Pubblicazione: (2025)

Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy
di: Rita Nogueiras‐Álvarez, et al.
Pubblicazione: (2024)

Initiation of lipid‐lowering therapy as primary prevention of cardiovascular disease in the elderly
di: José Manuel Vinuesa‐Hernando, et al.
Pubblicazione: (2024)

Natural products: Call for hard evidence
di: Francesco Visioli
Pubblicazione: (2024)

Integrating novel immunotherapeutic approaches in organ‐preserving therapies for bladder cancer
di: Éva Michaud, et al.
Pubblicazione: (2024)

Assessing ChatGPT's capability in understanding and reporting antiretroviral therapy drug–drug interaction effects: Quantitative and qualitative results from the ACCURATE‐DDI study
di: E. Ready, et al.
Pubblicazione: (2025)

Structure‐based discovery of thiamine uptake inhibitors
di: Florian Gabriel, et al.
Pubblicazione: (2025)

Evaluation of artificial intelligence‐generated drug therapy communication skill competencies in medical education
di: Kannan Sridharan, et al.
Pubblicazione: (2024)

Cyclodextrin‐based delivery of Annexin A1 mimetic Ac2–26 enhances anti‐inflammatory effect and prevents dengue‐induced lethality combined with antiviral therapy
di: Jenniffer Ramos Martins, et al.
Pubblicazione: (2026)

The clinical toxicity of advanced therapy medicinal products
di: Fraser J. H. Henderson, et al.
Pubblicazione: (2025)

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges
di: Rao Hu, et al.
Pubblicazione: (2026)

Biodiversity2Drugs—Renaissance of exploring nature‐derived peptides for GPCR ligand discovery
di: Christian W. Gruber, et al.
Pubblicazione: (2025)

Advancing antihypertensive drug development
di: Fay Pu, et al.
Pubblicazione: (2025)

Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer
di: Catharina J. P. Op 't Hoog, et al.
Pubblicazione: (2025)

Increased ATP production and P‐glycoprotein activity underlie the marked changes in blood–brain barrier transport of drugs in a mouse model of amyotrophic lateral sclerosis
di: Yijun Pan, et al.
Pubblicazione: (2025)

Unravelling the multifaceted actions of neurosteroids: Machine learning and in vitro screening for novel target discovery
di: Ajeet Kumar, et al.
Pubblicazione: (2025)

Opportunities of patient‐derived organoids in drug development
di: Antonia Büning, et al.
Pubblicazione: (2025)

Genetic polymorphisms influencing antihypertensive drug responses
di: Jana El Cheikh, et al.
Pubblicazione: (2024)

Chemistry/structural biology of psychedelic drugs and their receptor(s)
di: Ryan H. Gumpper, et al.
Pubblicazione: (2024)

Emerging therapeutic opportunities for psychedelic and related drugs
di: Susan Wonnacott, et al.
Pubblicazione: (2026)

Amylin analogues as a novel perspective in anti‐obesity therapy
di: Thomas A. Lutz
Pubblicazione: (2026)

Advanced therapy medicinal products (ATMPs) – An analysis of the global regulatory status
di: Allan Cramer, et al.
Pubblicazione: (2026)

Correction to “Genetic polymorphisms influencing antihypertensive drug responses”
Pubblicazione: (2025)

The eyes of the beholder: Perceived barriers to successful drug repurposing
di: Zsuzsanna Ida Petykó, et al.
Pubblicazione: (2025)

Exploring drug mechanisms through single‐cell proteomics
di: Yuzhi Sun, et al.
Pubblicazione: (2026)

The impact of pretreatment drug resistance on ainuovirine‐based antiviral therapy in HIV‐infected patients: A subgroup analysis from the RACER study
di: Q. Li, et al.
Pubblicazione: (2025)